|
CD19/CD22-bispecific CAR-T cells Clinical Trials
2 actively recruiting trials
Pipeline
Phase 2: 1Phase 1/2: 1
Top Sponsors
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1
- Beijing Tongren Hospital1
Indications
- Cancer2
- B-Cell Lymphoblastic Leukemia/Lymphoma1
- B-cell Acute Lymphoblastic Leukemia1
- B Cell Lymphoma1
- Diffuse Large B-Cell Lymphoma1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.